Bluebird Bio (BLUE) Takes Off on Promising Drug Results
December 10, 2014 at 09:44 AM EST
Shares of Cambridge, Massachusetts based Bluebird Bio, Inc. (BLUE) rocketed on Tuesday, against the backdrop of a mixed market on Wall Street. Bluebird’s stock was up 72.39%, rising by $35.29 per share, to close at $84.28 on volume of 8,209,814 shares. It was Bluebird’s highest close ever. On Monday night, the company announced that one Read the full article... Read the rest of Bluebird Bio (BLUE) Takes Off on Promising Drug Results at InvestorGuide.com .